DoD Bone Marrow Failure, Idea Development Award | W81XWH 20 BMFRP IDA

Opportunity Information: Apply for W81XWH 20 BMFRP IDA

The DoD Bone Marrow Failure, Idea Development Award is a competitive research funding opportunity run by the Department of Defense through the U.S. Army Medical Research Acquisition Activity (USAMRAA). It sits under the Bone Marrow Failure Research Program (BMFRP) and is structured to push the field toward the program's long-term vision of better understanding bone marrow failure (BMF) diseases and ultimately curing them. The award is meant for research that is genuinely idea-driven and forward-looking, emphasizing projects that can open up new directions rather than simply extending established lines of work.

At its core, this mechanism is designed to support innovative, high-impact concepts that are still grounded in solid scientific evidence. Proposals are expected to present a clearly stated, testable hypothesis backed by a strong scientific rationale, along with a research plan that is detailed, coherent, and feasible. The expectation is that the study has a high likelihood of uncovering new avenues of investigation, which means reviewers will be looking for novelty and potential payoff, but not at the expense of rigor. In practical terms, the best-fit projects are those that take a well-justified scientific leap, supported by credible preliminary logic or evidence, and that are paired with a carefully articulated approach that shows the team can execute and interpret the work.

Team qualifications matter heavily in this opportunity. The program indicates that personnel should bring a strong background in bone marrow failure disease research, signaling that while the ideas should be new, the investigators should not be new to the scientific space. This points to an emphasis on expertise and demonstrated capability, especially in a disease area where biological complexity and clinical translation can be challenging.

Relevance is also a clear requirement. The proposed research must connect to the needs of active duty Service members, Veterans, military beneficiaries, and/or the broader American public. That does not mean every project needs to be exclusively military-focused, but it does need to show a meaningful pathway to impact for these populations. Applicants typically address this by explaining the disease burden, the translational or clinical implications, and how the findings could inform prevention, diagnosis, treatment, or cure strategies that align with military and public health priorities.

Administratively, the opportunity (Funding Opportunity Number W81XWH 20 BMFRP IDA) was released as a discretionary funding announcement with the option of being awarded as either a grant or a cooperative agreement. It is categorized under Science and Technology and other Research and Development and is associated with CFDA number 12.420. Eligibility is listed as unrestricted, meaning a wide range of organization types may apply, subject to any additional eligibility notes in the full announcement. The posting was created on March 9, 2020, with an original closing date of August 5, 2020. The anticipated number of awards was five. The award ceiling is listed as 0, which typically indicates that a maximum dollar cap was not specified in the summary fields and would need to be confirmed in the full solicitation or related program guidance.

Overall, this award is best viewed as a DoD-backed launchpad for strong, hypothesis-driven BMF research ideas that are bold enough to shift the field, structured enough to be believable, and relevant enough to matter to military-connected communities and the public at large.

• The Department of Defense, Dept. of the Army -- USAMRAA in the science and technology and other research and development sector is offering a public funding opportunity titled "DoD Bone Marrow Failure, Idea Development Award" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 12.420.
• This funding opportunity was created on Mar 09, 2020.
• Applicants must submit their applications by Aug 05, 2020. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• The number of recipients for this funding is limited to 5 candidate(s).
• Eligible applicants include: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility.

Apply for W81XWH 20 BMFRP IDA

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: